Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to share news that the Company has received positive feedback from the U.S. Food and Drug Administration at their Pre-Investigational New Drug meeting regarding the use of Ifenprodil for the treatment of chronic cough.